The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,284
Sort by:
Systemic Sclerosis Market - 2023-2033
US$ 2,999.00
The Systemic Sclerosis Market was valued at US$ 2,259.64 Million in 2023 and is anticipated to reach US$ 4,132.66 Million by 2033, at a CAGR of 0.064 from 2026 to 2032. The report delivers in-depth in...
April 2026
210 pages
Acquired ichthyosis Treatment Market - 2025-2033
US$ 2,999.00
The Acquired ichthyosis Treatment Market was valued at US$ 91.6 million in 2025 and is anticipated to reach US$ 128.3 million by 2033, at a CAGR of 0.043 from 2026 to 2032. The report delivers in-dept...
April 2026
219 pages
Antiulcerant Drugs Market - 2025-2033
US$ 2,999.00
The Antiulcerant Drugs Market was valued at US$ 38.1 billion in 2025 and is anticipated to reach US$ 54.2 billion by 2033, at a CAGR of 0.045 from 2026 to 2032. The report delivers in-depth insights i...
April 2026
207 pages
Irritable Bowel Syndrome Treatment Market - 2025-2033
US$ 2,999.00
The Irritable Bowel Syndrome Treatment Market was valued at US$ 3.93 billion in 2025 and is anticipated to reach US$ 7.68 billion by 2033, at a CAGR of 0.088 from 2026 to 2032. The report delivers in-...
April 2026
219 pages
Metachromatic leukodystrophy Treatment Market 2026
US$ 2,999.00
The Metachromatic leukodystrophy Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.063 from 2026 to 2032. The report delivers in-depth insights into key market dynamics...
April 2026
217 pages
Acute Renal Failure Therapeutics Market - 2025-2033
US$ 2,999.00
The Acute Renal Failure Therapeutics Market was valued at US$ 6.60 billion in 2025 and is anticipated to reach US$ 13.05 million by 2033, at a CAGR of 0.089 from 2026 to 2032. The report delivers in-d...
April 2026
217 pages
Global Pharmaceutical Excipients Market Size Study and Forecast by Functionality (Binders and Adhesives, Disintegrants, Coating Material, Coloring Agents, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidents, Chelating Agents, Antifoaming Agents, and Others), by Dosage Form (Solid, Semi-Solid, and Liquid), by Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, and Other Excipients), by End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, and Others), by Distribution Channel (Direct Tender, Retail Sales, and Others), and Regional Forecasts 2026-2035
US$ 3,750.00
Pharmaceutical excipients are inactive substances formulated alongside active pharmaceutical ingredients (APIs) to support the manufacturing process, enhance drug stability, improve bioavailability, a...
April 2026
285 pages
Emerging Drugs: Global Markets
US$ 2,950.00
The report analyzes the trends in the global emerging drugs market. It includes global revenue ($ billions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The...
April 2026
93 pages
Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2026-2034
US$ 3,999.00
The global gaucher disease market size reached USD 1.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 5.76% durin...
April 2026
148 pages
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2026-2034
US$ 3,999.00
The global infantile spasms therapeutics market size reached USD 3.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.3 Billion by 2034, exhibiting a growth rate (CAGR)...
April 2026
136 pages
Acquired Orphan Blood Diseases Therapeutics Market Report by Therapy (Recombinant Factor, Immunoglobulin Infusion Therapy, Activated Prothrombin Complex Concentrate, Thrombopoietin Receptor Agonists, and Others), Disease Indication (Acquired Agranulocytosis, Acquired Hemophilia, Acquired Von Willebrand Syndrome, Paroxysmal Nocturnal Hemoglobinuria (PNH), Myelodysplastic Syndrome, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), and Region 2026-2034
US$ 3,999.00
The global acquired orphan blood diseases therapeutics market size reached USD 10.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 18.7 Billion by 2034, exhibiting a gro...
April 2026
147 pages
Oral Antibiotics Market Report by Class (Beta Lactam and Beta Lactamase Inhibitors, Quinolone, Macrolide, and Others), Application (Community-acquired Respiratory Tract Infections (CARTIs), Urinary Tract Infections (UTIs), Dental and Others), Drug Origin (Natural, Semisynthetic, Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic, Narrow Spectrum Antibiotic), Drug Type (Branded, Generics), and Region 2026-2034
US$ 3,999.00
The global oral antibiotics market size reached USD 21,749.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 28,759.4 Million by 2034, exhibiting a growth rate (CAGR) of...
April 2026
142 pages
Opioids Market Report by Product Type (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone), Application (Pain Management, Cough Treatment, Diarrhea Treatment, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores, and Others), and Region 2026-2034
US$ 3,999.00
The global opioids market size reached USD 23.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 29.2 Billion by 2034, exhibiting a growth rate (CAGR) of 2.55% during 2026...
April 2026
146 pages
Peptide Therapeutics Market Size, Share, Trends and Forecast by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region, 2026-2034
US$ 3,999.00
The global peptide therapeutics market size was valued at USD 49.7 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 92.6 Billion by 2034, exhibiting a CAGR of 6.95% duri...
April 2026
146 pages
Binder Excipients Market Report by Product Type (Cellulosics, Lactose, Polyols, Povidones, Starch and Polysaccharides, Co-Processed Compressible Excipients, and Others), Application (Tablets and Capsules, Solution Based), and Region 2026-2034
US$ 3,999.00
The global binder excipients market size reached USD 1.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.3 Billion by 2034, exhibiting a growth rate (CAGR) of 3.77% dur...
April 2026
135 pages
Human Chorionic Gonadotropin (HCG) Market Report by Technology (Natural Source Extraction, Recombinant Technology), Therapeutic Area (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment, and Others), End User (Fertility Clinics, Research Institutions, and Others), and Region 2026-2034
US$ 3,999.00
The global human chorionic gonadotropin (HCG) market size reached USD 1,103.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,905.9 Million by 2034, exhibiting a growth...
April 2026
142 pages
Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2026-2034
US$ 3,999.00
The global clinical nutrition market size reached USD 59.8 Billion in 2025. Looking forward, the market is expected to reach USD 111.4 Billion by 2034, exhibiting a growth rate (CAGR) of 6.94% during...
April 2026
135 pages
Contrast Media Market Report by Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), Modality (X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound), Application (Radiology, Interventional Radiology, Interventional Cardiology), Route of Administration (Intravenous/Intrarterial, Oral Route, Rectal Route, and Others), End User (Hospital, Clinics and Ambulatory Surgery Centers, Diagnostic Imaging Centers), and Region 2026-2034
US$ 3,999.00
The global contrast media market size reached USD 5.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.41% during...
April 2026
144 pages
Fabry Disease Market Report by Type (Type 1, Type 2, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2026-2034
US$ 3,999.00
The global fabry disease market size reached USD 2.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 5.78% during...
April 2026
142 pages
Immunotherapy Drugs Market Report by Drug Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2026-2034
US$ 3,999.00
The global immunotherapy drugs market size reached USD 246.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 464.3 Billion by 2034, exhibiting a growth rate (CAGR) of 7.0...
April 2026
138 pages
Magnetite Nanoparticles Market Report by Type (Iron Based, Cobalt Based), Physical Form (Nanopowder, Solution, Dispersion), Application (Bio-medical, Electronics, Wastewater Treatment, Energy, and Others), and Region 2026-2034
US$ 3,999.00
The global magnetite nanoparticles market size reached USD 98.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 213.2 Million by 2034, exhibiting a growth rate (CAGR) of...
April 2026
138 pages
North America Analgesics Market Size, Share, Trends and Forecast by Type, Drug Class, Route of Administration, Pain Type, Application, and Country, 2026-2034
US$ 3,999.00
The North America analgesics market size was valued at USD 25.6 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 33.1 Billion by 2034, exhibiting a CAGR of 2.78% from 20...
April 2026
137 pages
North America Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Country 2026-2034
US$ 3,999.00
The North America hormone replacement therapy market size reached USD 4.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.2 Billion by 2034, exhibiting a growth rate (C...
April 2026
137 pages
Onychomycosis Treatment Market Report by Disease Type (Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis, Candidal Onychomycosis, and Others), Treatment Type (Laser Therapy, Photodynamic Therapy, Drug Treatment), Drug Class (Allylamine, Azole, Griseofulvin, and Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, and Others), and Region 2026-2034
US$ 3,999.00
The global onychomycosis treatment market size reached USD 3.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1...
April 2026
150 pages
Testosterone Replacement Therapy Market Report by Product Type (Oral implants, Injections, Patches, Creams/Gels, Gums/Buccal Adhesives, and Others), Active Ingredients (Testosterone, Methyl Testosterone, Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2026-2034
US$ 3,999.00
The global testosterone replacement therapy market size reached USD 2.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2034, exhibiting a growth rate (CAG...
April 2026
145 pages
Anti-infectives Market Report by Type (Antibacterial, Antifungal, Antiviral), Route of Administration (Topical, Oral, Intravenous (IV), and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Speciality Pharmacies, Online Stores, and Others), and Region 2026-2034
US$ 3,999.00
The global anti-infectives market size reached USD 142.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 182.9 Billion by 2034, exhibiting a growth rate (CAGR) of 2.70% d...
April 2026
145 pages
Hyperphosphatemia Drugs Market Report by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 3,999.00
The global hyperphosphatemia drugs market size reached USD 4.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2034, exhibiting a growth rate (CAGR) of 6.4...
April 2026
140 pages
